Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 324 for “"Pai-1"”.
-
Structure-activity relationships of PAI-1 inhibitors
… inhibition of plasminogen activator inhibitor-1 (PAI-1) is anticipated to increase our understanding of various human ailments with which high levels of PAI-1 have been associated, including diabetes, stroke, and atherosclerosis. Previous accounts have reported the synthesis of inhibitors that …
-
Cloning and characterization of mink plasminogen activator inhibitor type 1 (PAI-1) cDNA and the regulation of mink PAI-1 expression at mRNA level
<p>Mink plasminogen activator inhibitor type 1 (PAI-1) is a glycoprotein with molecular weight about 50 kD and is highly regulated in cultured cells. In mink lung CCL64 epithelial cells, epidermal growth factor (EGF), transforming growth factor-[beta] (TGF-[beta]), and 12-O-tetradecanoyl …
-
SERPINE1/PAI-1 role on blood flow, stalling and vessel width in stroke
… encoding for Plasminogen Activator-Inhibitor-1 (PAI-1), is highly expressed along blood vessels following photothrombotic stroke in the rodent somatosensory cortex. Therefore, we explored the role of Serp1/PAI-1 on cortical blood flow and its potential downstream effects following experimentally …
-
New Insights Into An Old Interaction: Developing A Model For PAI-1:VN Interactions
… human Plasminogen Activator Inhibitor 1 (PAI-1) is most often found in complex with Vitronectin (VN), an ~62kDa glycoprotein. Research has shown PAI-1 and VN form higher order complexes in tissues, and our work indicates a 2:1 (PAI-1:VN) stoichiometry for these complexes. A logical model …
-
Pinpointing the Molecular Basis for Metal Ion Effects on Plasminogen Activator Inhibitor-1 (PAI-1)
<p>Plasminogen activator inhibitor type-1 (PAI-1) specifically inhibits the proteases tissue type plasminogen activator and urokinase plasminogen activator to control the activation of fibrinolysis. Vitronectin interacts with PAI-1 primarily through the somatomedin B (SMB) domain to stabilize and …
-
Der Einfluss von HMG-CoA-Reduktase-Hemmern auf die PAI-1-Synthese in humanen Zellkulturen
… durch TGF-β1 (1 ng/ml) stimulierte Synthese von PAI-1 signifikant, nicht jedoch Pravastatin. Die Senkung ist dabei abhängig vom eingesetzten Statin und der Konzentration. Die Reduktion der PAI-1-Synthese ist umso stärker, je höher die Statindosis ist. Nur Simvastatin zeigte bei 10 mikroM keine …
-
The association between alcohol consumption, PAI-1 activity and fibrinogen concentration in black South Africans
… levels, plasminogen activator inhibitor type-1 (PAI-1) and fibrinogen, which are two of the best known haemostatic risk factors, may increase the risk of CVD. Fibrinogen concentrations have been shown to be higher, and PAI-1 levels to be significantly lower, in black South African populations …
-
Expression of vitronectin in eurkaryotic cells : evaluation of PAI-1 binding and implications for gene therapy
… two ligands, plasminogen activator inhibitor-1 (PAI-1) and the urokinase receptor (uPAR). However, ligand binding sites for these proteins have also been identified in the heparin binding domain near the carboxy-terminus. The goal of this research was two fold: to determine if the high affinity …
-
The PAI-1-vitronectin-vimentin ternary complex : mechanism of extracellular assembly and role in transplant vasculopathy
… state of plasminogen activator inhibitor type-1 (PAI-1) is prolonged when it forms a complex with vitronectin (VN), a major serum protein. Active PAI-1 in the PAI-1:VN complex serves many functions related to fibrinolysis and cell migration but key to these effects is its extracellular …
-
Modulation of TGFβ-Induced PAI -1 Expression by Changes in Actin Polymerization in Human Mesangial Cells
… plasminogen actuator inhibitor type-1 (PAI-1; expression. PAI-1 inhibits ECM degradation by tissue- (tPA) and urokinase-type (uPA) plasminogen activators. Additionally, the Rho family of GTPases is required for TGFβ-induced PAI-1 expression. Since, regulation of actin cytoskeletal …
-
The inhibition of PAI-1 for restoration of skeletal muscle and skin repair in diabetes mellitus
… with many systemic complications, including impairments in skeletal muscle and cutaneous repair following injury. Plasminogen activator inhibitor 1 (PAI-1), the primary inhibitor of the fibrinolytic system, plays a critical role in the regulation and progression of tissue repair via controlling …
-
A Tale of Two Serpins: Pathologic and Protective Roles of AGT and PAI-1 in Metabolic and Cardiovascular Disease
… (AGT) and plasminogen activator inhibitor-1 (PAI-1), in preclinical models of metabolic and cardiovascular disease to identify novel mechanisms that may inform future therapeutic strategies. AGT, a non-inhibitory serpin, is the unique substrate of the renin-angiotensin system (RAS). While …
-
Auswirkung von Genvariationen im PAI-1- und Leptin-System bei Patienten mit koronarer Herzerkrankung und Restenose nach perkutaner koronarer Intervention
Die Bedeutung von PAI-1 als kardiovaskulärer Risikofaktor ist bekannt. Erhöhte Plasmaspiegel von PAI-1 zeigen in früheren Studien eine Assoziation zum Auftreten kardiovaskulärer Erkrankungen. PAI-1-Gen Polymorphismen könnten Einfluss auf die PAI-1 Expression nehmen und somit ebenfalls mit …
-
Bedeutung des Urokinasetyp-Plasminogenaktivators (uPA), des Plasminogenaktivator-Inhibitors 1 (PAI-1) und des Plasminogenaktivator-Inhibitors 2 (PAI-2) beim Mammakarzinom
Prognoseeinschätzung, Therapieoption des frühen Mammacarcinoms
Page 1 of 17